← Leaderboards
Aleksey V Matveyenko
University Of California Los Angeles
$6,776,230
Attributed
$8,209,740
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,209,740 · 5
By mechanism
R01$6,657,327 · 2
R44$1,021,719 · 1
K01$426,518 · 1
F32$104,176 · 1
Top collaborators
- Michael F Romero4 shared
- Christopher M Adams1 shared
- Scott Matthew Ebert1 shared
- John Jeffrey Talley1 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Michael Frederick Wells$1,070,617
- Chentao Lin$9,733,912
- Xian-Jie Yang$9,325,084
- A. Janet Tomiyama$3,227,752
- Paul Wender$20,449,594
Others in their field
Top investigators on “Beta Cell”
- Jeffrey P Krischer · University Of South Florida$200,020,568
- John M Lachin · George Washington University$137,809,898
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- Mark A Magnuson · Vanderbilt University$88,190,667
- Mitchell A. Lazar · University Of Pennsylvania$60,855,549
- Randall J Bateman · Washington University$46,897,850
Research focus
Beta CellResponseInsulin SecretionInsulinRegulationIsletMediatingNon-Insulin-Dependent Diabetes MellitusStructure Of Beta Cell Of IsletFunctional DisorderCell PhysiologyMolecularGenesDiabetes MellitusAttenuatedIn VivoHyperglycemiaExposure ToCircadian RhythmsPhysiologicalGenetic TranscriptionTranscriptional RegulationGlucoseFailure
Grant awards (24)
Development of novel therapeutics for obesity and type 2 diabetes$1,021,719
R44 · FY2025 · DK
Role of Circadian Misalignment in Beta-cell Failure in Type 2 Diabetes$516,603
R01 · FY2025 · DK · contact PI
Role of Circadian Misalignment in Beta-cell Failure in Type 2 Diabetes$495,940
R01 · FY2024 · DK · contact PI
Role of Circadian Misalignment in Beta-cell Failure in Type 2 Diabetes$531,953
R01 · FY2023 · DK · contact PI
Role of pH-mediated metabolic reprogramming in β cell failure in Type 2 Diabetes Mellitus$397,500
R01 · FY2023 · DK · contact PI
Role of pH-mediated metabolic reprogramming in β cell failure in Type 2 Diabetes Mellitus$141,941
R01 · FY2023 · DK · contact PI
Role of Circadian Misalignment in Beta-cell Failure in Type 2 Diabetes$412,341
R01 · FY2022 · DK · contact PI
Role of pH-mediated metabolic reprogramming in β cell failure in Type 2 Diabetes Mellitus$397,500
R01 · FY2022 · DK · contact PI
Role of Circadian Misalignment in Beta-cell Failure in Type 2 Diabetes$412,341
R01 · FY2021 · DK · contact PI
Role of pH-mediated metabolic reprogramming in β cell failure in Type 2 Diabetes Mellitus$397,500
R01 · FY2021 · DK · contact PI
Role of Circadian Misalignment in Beta-cell Failure in Type 2 Diabetes$412,341
R01 · FY2020 · DK · contact PI
Role of Circadian Misalignment in Beta-cell Failure in Type 2 Diabetes$412,341
R01 · FY2019 · DK · contact PI
Role of Circadian Misalignment in Beta-cell Failure in Type 2 Diabetes$412,341
R01 · FY2018 · DK · contact PI
Role of Circadian Misalignment in Beta-cell Failure in Type 2 Diabetes$345,825
R01 · FY2017 · DK · contact PI
Role of Circadian Misalignment in Beta-cell Failure in Type 2 Diabetes$345,825
R01 · FY2016 · DK · contact PI
Role of Circadian Misalignment in Beta-cell Failure in Type 2 Diabetes$345,825
R01 · FY2015 · DK · contact PI
Role of Circadian Misalignment in Beta-cell Failure in Type 2 Diabetes$296,080
R01 · FY2014 · DK · contact PI
Role of Circadian Misalignment in Beta-cell Failure in Type 2 Diabetes$48,180
R01 · FY2014 · DK · contact PI
Role of Circadian Misalignment in Beta-cell Failure in Type 2 Diabetes$334,950
R01 · FY2013 · DK · contact PI
The role of melatonin signaling in regulation of beta-cell survival and function$143,302
K01 · FY2012 · DK · contact PI
The role of melatonin signaling in regulation of beta-cell survival and function$143,302
K01 · FY2011 · DK · contact PI
The role of melatonin signaling in regulation of beta-cell survival and function$139,914
K01 · FY2010 · DK · contact PI
Potential mechanism(s) of impaired pulsatile insulin secretion and action in Type$52,898
F32 · FY2008 · DK · contact PI
Potential mechanism(s) of impaired pulsatile insulin secretion and action in Type$51,278
F32 · FY2007 · DK · contact PI